Edwards Lifesciences Corp. (EW)

219.66
NYSE : Health Technology
Prev Close 215.11
Day Low/High 215.98 / 220.00
52 Wk Low/High 136.44 / 228.19
Avg Volume 1.18M
Exchange NYSE
Shares Outstanding 207.97M
Market Cap 44.74B
EPS 3.50
P/E Ratio 64.16
Div & Yield N.A. (N.A)

Latest News

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences Reports Second Quarter Results

IRVINE, Calif., July 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended...

Edwards Lifesciences Has Formula for Long-Lasting Rally

Edwards Lifesciences Has Formula for Long-Lasting Rally

EW has had some corrections and pullbacks along the way during this long and strong rally from $80 to nearly $200, but its price target is $240.

Investors Flock to Tech: Cramer's 'Mad Money' Recap (Tuesday 7/9/19)

Investors Flock to Tech: Cramer's 'Mad Money' Recap (Tuesday 7/9/19)

Jim Cramer says the important thing is recognizing the slowdown exists and knowing how to deal with it.

Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019

Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019

IRVINE, Calif., July 9, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter...

IIROC Trading Resumption - EW

IIROC Trading Resumption - EW

VANCOUVER, June 25, 2019 /CNW/ - Trading resumes in: Company: East West Petroleum Corp.

IIROC Trading Halt - EW

IIROC Trading Halt - EW

VANCOUVER, June 24, 2019 /CNW/ - The following issues have been halted by IIROC: Company: East West Petroleum Corp.

Edwards Comments On Updated TAVR National Coverage Determination

Edwards Comments On Updated TAVR National Coverage Determination

IRVINE, Calif., June 21, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the final updated U.

Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

IRVINE, Calif., June 4, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the 40 th Annual Global...

Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital Corporation

Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital Corporation

IRVINE, Calif., June 3, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an...

Edwards Announces Milestones For Transcatheter Mitral Program

Edwards Announces Milestones For Transcatheter Mitral Program

PARIS, May 22, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its...

Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

COMMENCE Trial Four-Year Data Presented at the AATS 99th Annual Meeting

Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

IRVINE, Calif., May 1, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will host its Annual Meeting of Stockholders on Wednesday,...

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences Reports First Quarter Results

IRVINE, Calif., April 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended...

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

Cramer says these red-hot and hopelessly overvalued IPOs are signs people are too bullish. Here's your game plan for next week.

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.

Edwards Lifesciences Completes Acquisition Of CASMED

Edwards Lifesciences Completes Acquisition Of CASMED

IRVINE, Calif., April 18, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the completion of its acquisition of...

IIROC Trading Resumption - EW

IIROC Trading Resumption - EW

VANCOUVER, April 9, 2019 /CNW/ - Trading resumes in: Company: East West Petroleum Corp.

Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019

Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019

IRVINE, Calif., April 9, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter...

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

The biggest IPO of the year so far is likely to set a trend, Jim Cramer says.

Edwards Lifesciences Gains on Positive Heart Trial Results

Edwards Lifesciences Gains on Positive Heart Trial Results

The medical research and device company announces positive results from its recent aortic valve surgical treatment trial.

New Relic, Edwards Lifesciences, Aphria: 'Mad Money' Lightning Round

New Relic, Edwards Lifesciences, Aphria: 'Mad Money' Lightning Round

Jim Cramer takes a look at New Relic, Edwards Lifesciences, Aphria, NovaGold Resources, Insperity and more.

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.

The New #198 Most Shorted S&P 500 Component: Edwards Lifesciences

The New #198 Most Shorted S&P 500 Component: Edwards Lifesciences

The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Walmart, IBM, AES and More: 'Mad Money' Lightning Round

Walmart, IBM, AES and More: 'Mad Money' Lightning Round

Jim Cramer weighs in on Walmart, AES, IBM and more.

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

Conflicting data about the economy should give the Federal Reserve pause.

Dell Technologies, Vail Resorts, Mastercard: 'Mad Money' Lightning Round

Dell Technologies, Vail Resorts, Mastercard: 'Mad Money' Lightning Round

Jim Cramer weighs in on Dell Technologies, Vail Resorts, Mastercard, CyberArk, iRobot, Marriott Vacations, TherapeuticsMD, Edwards Lifesciences.

TheStreet Quant Rating: B+ (Buy)